Recovery rate of NTM from AFB smear-positive sputum specimens at a medical centre in South Korea

International Journal of Tuberculosis and Lung Disease

Volumn 9, Issue 9, 2005, Pages 1046-1051

  Jeon, K ^a   Koh, Won Jung ^a   Kwon, O J ^a   Suh, G Y ^a   Chung, M P ^a   Kim, H ^a   Lee, N Y ^a   Park, Y K ^b   Bai, G H ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Korean Institute of Tuberculosis   (South Korea)

Author keywords

Atypical mycobacteria; Korea; Mycobacterium tuberculosis; Pulmonary tuberculosis; Sputum

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFOXITIN; CLARITHROMYCIN; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ACID FAST BACTERIUM; ADULT; AGED; ARTICLE; ATYPICAL MYCOBACTERIUM; BACTERIUM CULTURE; CHRONIC DISEASE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; FEMALE; HUMAN; KOREA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPUTUM SMEAR; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TUBERCULOSIS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; KOREA; MALE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS; RETROSPECTIVE STUDIES; SPUTUM; TUBERCULOSIS, PULMONARY;

EID: 27644463876     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione M C. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999; 282: 677-686.
2. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. 3rd ed. Geneva, Switzerland: WHO, 2003.
3. World Health Organization, International Union Against Tuberculosis and Lung Disease, Royal Netherlands Tuberculosis Association. Revised international definitions in tuberculosis control. Int J Tuberc Lung Dis 2001; 5: 213-215.
4. American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000; 161: 1376-1395.
5. Levy H, Feldman C, Sacho H, van der Meulen H, Kallenbach J, Koornhof H. A reevaluation of sputum microscopy and culture in the diagnosis of pulmonary tuberculosis. Chest 1989; 95: 1193-1197.
6. Coll P, Garrigo M, Moreno C, Marti N. Routine use of Gen-Probe Amplified Mycobacterium Tuberculosis Direct (MTD) test for detection of Mycobacterium tuberculosis with smear-positive and smear-negative specimens. Int J Tuberc Lung Dis 2003; 7: 886-891.
7. Anargyros P, Astill D S, Lim I S. Comparison of improved BACTEC and Lowenstein-Jensen media for culture of mycobacteria from clinical specimens. J Clin Microbiol 1990; 28: 1288-1291.
8. Lipsky B A, Gates J, Tenover F C, Plorde J J. Factors affecting the clinical value of microscopy for acid-fast bacilli. Rev Infect Dis 1984; 6: 214-222.
9. Gordin F, Slutkin G. The validity of acid-fast smears in the diagnosis of pulmonary tuberculosis. Arch Pathol Lab Med 1990; 114: 1025-1027.
10. Yajko D M, Nassos P S, Sanders C A, Madej J J, Hadley W K. High predictive value of the acid-fast smear for Mycobacterium tuberculosis despite the high prevalence of Mycobacterium avium complex in respiratory specimens. Clin Infect Dis 1994; 19: 334-336.
11. Stone B L, Burman W J, Hildred M V, Jarboe E A, Reves R R, Wilson M L. The diagnostic yield of acid-fast-bacillus smear-positive sputum specimens. J Clin Microbiol 1997; 35: 1030-1031.
12. Wright P W, Wallace R J Jr, Wright N W, Brown B A, Griffith D E. Sensitivity of fluorochrome microscopy for detection of Mycobacterium tuberculosis versus nontuberculous mycobacteria. J Clin Microbiol 1998; 36: 1046-1049.
13. Centers for Disease Control and Prevention. Update: nucleic acid amplification tests for tuberculosis. MMWR 2000; 49: 593-594.
14. Korean Center for Disease Control and Prevention. Guidelines for the control of tuberculosis 2004. Seoul, Republic of Korea: Korean CDC, 2004. [in Korean]
15. Metchock B G, Nolte F S, Wallace R J Jr. Mycobacterium. In: Murray P R, Baron E J, Pfaller M A, Tenover F C, Yolken R H, eds. Manual of Microbiology. 7th ed. Washington, DC: American Society for Microbiology, 1999: pp 399-437.
16. Lee H, Park H J, Cho S N, Bai G H, Kim S J. Species identification of mycobacteria by PCR-restriction fragment length polymorphism of the rpoB gene. J Clin Microbiol 2000; 38: 2966-2971.
17. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997; 156: S1-S25.
18. Koh W J, Kwon O J, Lee K S. Nontuberculous mycobacterial pulmonary diseases in immunocompetent patients. Korean J Radiol 2002; 3: 145-157.
19. Tsukamura M, Kita N, Shimoide H, Arakawa H, Kuze A. Studies on the epidemiology of nontuberculous mycobacteriosis in Japan. Am Rev Respir Dis 1988; 137: 1280-1284.
20. Hosker H S, Lam C W, Ng T K, Ma H K, Chan S L. The prevalence and clinical significance of pulmonary infection due to non-tuberculous mycobacteria in Hong Kong. Respir Med 1995; 89: 3-8.
21. Seung K J, Bai G H, Kim S J, Lew W J, Park S K, Kim J Y. The treatment of tuberculosis in South Korea. Int J Tuberc Lung Dis 2003; 7: 912-919.
22. Korean Center for Disease Control and Prevention. Annual report on the notified tuberculosis patients in Korea. Seoul, Republic of Korea: Korean CDC, 2004. [in Korean].
23. O'Brien R J, Geiter L J, Snider D E Jr. The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis 1987; 135: 1007-1014.
24. Christensen E E, Dietz G W, Ahn C H, et al. Pulmonary manifestations of Mycobacterium intracellularis. Am J Roentgenol 1979; 133: 59-66.
25. Prince D S, Peterson D D, Steiner R M, et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 1989; 321: 863-868.
26. Tanaka E, Amitani R, Niimi A, Suzuki K, Murayama T, Kuze F. Yield of computed tomography and bronchoscopy for the diagnosis of Mycobacterium avium complex pulmonary disease. Am J Respir Crit Care Med 1997; 155: 2041-2046.
27. Huang J H, Kao P N, Adi V, Ruoss S J. Mycobacterium avium-intracellulare pulmonary infection in HIV-negative patients without preexisting lung disease: diagnostic and management limitations. Chest 1999; 115: 1033-1040.
28. Griffith D E, Girard W M, Wallace R J Jr. Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. Am Rev Respir Dis 1993; 147: 1271-1278.
29. Hartman T E, Swensen S J, Williams D E. Mycobacterium avium-intracellulare complex: evaluation with CT. Radiology 1993; 187: 23-26.
30. Swensen S J, Hartman T E, Williams D E. Computed tomographic diagnosis of Mycobacterium avium-intracellulare complex in patients with bronchiectasis. Chest 1994; 105: 49-52.
31. Moore E H. Atypical mycobacterial infection in the lung. CT appearance. Radiology 1993; 187: 777-782.
32. Jeong Y J, Lee K S, Koh W J, Han J, Kim T S, Kwon O J. Non-tuberculous mycobacterial pulmonary infection in immunocompetent patients: comparison of thin-section CT and histopathologic findings. Radiology 2004; 231: 880-886.
33. Fujita J, Ohtsuki Y, Shigeto E, et al. Pathological findings of bronchiectases caused by Mycobacterium avium intracellulare complex. Respir Med 2003; 97: 933-938.